New Enterprise Associates 16, L.P. 13D and 13G filings for Trevi Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-03-20 7:55 pm Unchanged |
2025-03-18 | 13D | Trevi Therapeutics, Inc. TRVI |
New Enterprise Associates 16, L.P. | 15,074,080 15.000% |
0 (Unchanged) |
Filing |
| 2024-11-08 6:57 pm Unchanged |
2024-11-06 | 13D | Trevi Therapeutics, Inc. TRVI |
New Enterprise Associates 16, L.P. | 15,074,080 18.700% |
0 (Unchanged) |
Filing |
| 2024-05-21 6:34 pm Purchase |
2024-05-07 | 13D | Trevi Therapeutics, Inc. TRVI |
New Enterprise Associates 16, L.P. | 15,074,080 20.300% |
703,704 (+4.90%) |
Filing |
| 2022-04-25 5:04 pm Purchase |
2022-04-11 | 13D | Trevi Therapeutics, Inc. TRVI |
New Enterprise Associates 16, L.P. | 14,370,376 42.500% |
6,580,526 (+84.48%) |
Filing |
| 2021-11-02 09:09 am Purchase |
2021-10-18 | 13D | Trevi Therapeutics, Inc. TRVI |
New Enterprise Associates 16, L.P. | 7,789,850 36.100% |
1,851,852 (+31.19%) |
Filing |